HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David Johnson Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mayers, I. Articles by Radomski, M. W. Search for Related Content PubMed PubMed Citation Articles by Mayers, I. Articles by Radomski, M. W.

J Thorac Cardiovasc Surg 1999;117:1009-1016
© 1999 Mosby, Inc.

CARDIOPULMONARY SUPPORT AND PHYSIOLOGY

INCREASED NITRIC OXIDE SYNTHASE ACTIVITY AFTER CANINE CARDIOPULMONARY BYPASS IS SUPPRESSED BY S-NITROSOGLUTATHIONE

From Departments of Medicine^a and Pharmacology,^b University of Alberta, Edmonton, and the Departments of Medicine^c and Anaesthesia,^d University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

This work was supported by a grant from the Saskatchewan Heart and Stroke Foundation.

Received for publication June 2, 1998. Revisions requested Aug 10, 1998. Revisions received Jan 21, 1999. Accepted for publication Jan 21, 1999. Address for reprints: Irvin Mayers, MD, Department of Medicine, Walter C. Mackenzie Health Sciences Centre, Edmonton, Alberta, Canada.

Objectives: Hemodynamic instability and generalized organ dysfunction are common after cardiopulmonary bypass in human beings. Previous studies have suggested that alterations of nitric oxide metabolism may be associated with this impaired function. Using a canine model we tested whether nitric oxide synthase activity is increased after cardiopulmonary bypass. We also tested whether administration of a nitric oxide donor can influence nitric oxide synthase activity after cardiopulmonary bypass.
Methods: After induction of anesthesia, dogs were randomized to receive cardiopulmonary bypass (n = 12) or to serve as controls (n = 12). They were further randomized to receive a continuous infusion of a nitric oxide donor, S-nitrosoglutathione, or an equivalent volume of placebo. Cardiopulmonary bypass was maintained for 90 minutes, and then 4 hours later dogs were put to death. Cardiac and coronary artery sections were frozen in liquid nitrogen immediately after death for later determination of nitric oxide synthase activity using a citrulline assay.
Results: After cardiopulmonary bypass, 4 of 6 placebo-treated but only 2 of 6 S-nitrosoglutathione–treated animals required phenylephrine infusion (3.1 ± 3.1 µg/min and 0.2 ± 0.4 µg/min, respectively, P = .05) to maintain a predetermined blood pressure. Furthermore, after cardiopulmonary bypass, Ca²⁺-dependent nitric oxide synthase activity in the left ventricle, atrium, and coronary artery did not increase compared with activity in the control animals, but Ca²⁺-independent nitric oxide synthase activity did increase (P = .005): left ventricle (+28.0% ± 9.0%), atrium (+45.0% ± 12.0%) and coronary artery (+17.0% ± 12.0%).
Conclusions: We have found that (1) cardiopulmonary bypass results in increased activity of Ca²⁺-independent nitric oxide synthase, (2) S-nitrosoglutathione can prevent the increase of Ca²⁺-independent nitric oxide synthase after cardiopulmonary bypass, and (3) Ca²⁺-independent nitric oxide synthase may contribute to hemodynamic dysfunction after cardiopulmonary bypass.

This article has been cited by other articles:

				I. Mayers, T. Hurst, A. Radomski, D. Johnson, S. Fricker, G. Bridger, B. Cameron, M. Darkes, and M. W. Radomski Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 661 - 668. [Abstract] [Full Text] [PDF]

				U. Mehlhorn and W. Bloch Role of cardiopulmonary bypass and cardioplegic arrest in the regulation of cardiac nitric oxide synthase activity J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 418 - 419. [Full Text] [PDF]

				I. Mayers, T. Hurst, L. Puttagunta, A. Radomski, T. Mycyk, G. Sawicki, D. Johnson, and M. W. Radomski Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 746 - 752. [Abstract] [Full Text] [PDF]